<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">MSJ</journal-id>
<journal-id journal-id-type="hwp">spmsj</journal-id>
<journal-id journal-id-type="nlm-ta">Mult Scler</journal-id>
<journal-title>Multiple Sclerosis Journal</journal-title>
<issn pub-type="ppub">1352-4585</issn>
<issn pub-type="epub">1477-0970</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1352458512451944</article-id>
<article-id pub-id-type="publisher-id">10.1177_1352458512451944</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Papers</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Predictors of driving in individuals with relapsing–remitting multiple sclerosis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Akinwuntan</surname><given-names>Abiodun Emmanuel</given-names></name>
<xref ref-type="aff" rid="aff1-1352458512451944">1</xref>
<xref ref-type="aff" rid="aff2-1352458512451944">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Devos</surname><given-names>Hannes</given-names></name>
<xref ref-type="aff" rid="aff3-1352458512451944">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Stepleman</surname><given-names>Lara</given-names></name>
<xref ref-type="aff" rid="aff4-1352458512451944">4</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Casillas</surname><given-names>Rhonda</given-names></name>
<xref ref-type="aff" rid="aff4-1352458512451944">4</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Rahn</surname><given-names>Rebecca</given-names></name>
<xref ref-type="aff" rid="aff2-1352458512451944">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Smith</surname><given-names>Suzanne</given-names></name>
<xref ref-type="aff" rid="aff2-1352458512451944">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Williams</surname><given-names>Mitzi Joi</given-names></name>
<xref ref-type="aff" rid="aff5-1352458512451944">5</xref>
</contrib>
</contrib-group>
<aff id="aff1-1352458512451944"><label>1</label>Department of Physical Therapy, Georgia Health Sciences University, Augusta, USA</aff>
<aff id="aff2-1352458512451944"><label>2</label>Department of Neurology, Georgia Health Sciences University, Augusta, USA</aff>
<aff id="aff3-1352458512451944"><label>3</label>Department of Rehabilitation Sciences, Katholieke Universiteit Leuven, Belgium</aff>
<aff id="aff4-1352458512451944"><label>4</label>Department of Psychiatry, Georgia Health Sciences University, Augusta, USA</aff>
<aff id="aff5-1352458512451944"><label>5</label>MS Center of Atlanta, USA</aff>
<author-notes>
<corresp id="corresp1-1352458512451944">Abiodun Emmanuel Akinwuntan, Department of Physical Therapy, Georgia Health Sciences University, 987 St Sebastian Way, Augusta GA, 30912, USA. Email: <email>aakinwuntan@georgiahealth.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>3</month>
<year>2013</year>
</pub-date>
<volume>19</volume>
<issue>3</issue>
<fpage>344</fpage>
<lpage>350</lpage>
<history>
<date date-type="received">
<day>9</day>
<month>4</month>
<year>2012</year>
</date>
<date date-type="rev-recd">
<day>14</day>
<month>5</month>
<year>2012</year>
</date>
<date date-type="accepted">
<day>23</day>
<month>5</month>
<year>2012</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<sec id="section1-1352458512451944">
<title>Background:</title>
<p>We previously reported that performance on the Stroke Driver Screening Assessment (SDSA), a battery of four cognitive tests that takes less than 30 min to administer, predicted the driving performance of participants with multiple sclerosis (MS) on a road test with 86% accuracy, 80% sensitivity, and 88% specificity.</p>
</sec>
<sec id="section2-1352458512451944">
<title>Objectives:</title>
<p>In this study, we further investigated if the addition of driving-related physical and visual tests and other previously identified cognitive predictors, including performance on the Useful Field of View test, will result in a better accuracy of predicting participants’ on-road driving performance.</p>
</sec>
<sec id="section3-1352458512451944">
<title>Methods:</title>
<p>Forty-four individuals with relapsing–remitting MS (age = 46 ± 11 years, 37 females) and Expanded Disability Status Scale values between 1 and 7 were administered selected physical, visual and cognitive tests including the SDSA. The model that explained the highest variance of participants’ performance on a standardized road test was identified using multiple regression analysis. A discriminant equation containing the tests included in the best model was used to predict pass or fail performance on the test.</p>
</sec>
<sec id="section4-1352458512451944">
<title>Results:</title>
<p>Performance on 12 cognitive and three visual tests were significantly associated with performance on the road test. Five of the tests together explained 59% of the variance and predicted the pass or fail outcome of the road test with 91% accuracy, 70% sensitivity, and 97% specificity.</p>
</sec>
<sec id="section5-1352458512451944">
<title>Conclusion:</title>
<p>Participants’ on-road performance was more accurately predicted by the model identified in this study than using only performance on the SDSA test battery. The five psychometric/off-road tests should be used as a screening battery, after which a follow-up road test should be conducted to finally decide the fitness to drive of individuals with relapsing–remitting MS. Future studies are needed to confirm and validate the findings in this study.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Physical function</kwd>
<kwd>visual function</kwd>
<kwd>cognition</kwd>
<kwd>driving</kwd>
<kwd>multiple sclerosis</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section6-1352458512451944" sec-type="intro">
<title>Introduction</title>
<p>Driving ability is affected in many individuals with multiple sclerosis (MS). Data analysis of a 10-year period showed that the accident rate per 1000 person-years was three times higher for individuals with MS than age-matched healthy controls.<sup><xref ref-type="bibr" rid="bibr1-1352458512451944">1</xref></sup> Increased risk levels were also reported in other studies<sup><xref ref-type="bibr" rid="bibr2-1352458512451944">2</xref>,<xref ref-type="bibr" rid="bibr3-1352458512451944">3</xref></sup> even with reduced driving frequency.<sup><xref ref-type="bibr" rid="bibr4-1352458512451944">4</xref></sup></p>
<p>A review of the literature showed that driving-related motor, visual and cognitive skills are negatively affected in individuals with MS.<sup><xref ref-type="bibr" rid="bibr1-1352458512451944">1</xref><xref ref-type="bibr" rid="bibr2-1352458512451944"/><xref ref-type="bibr" rid="bibr3-1352458512451944"/><xref ref-type="bibr" rid="bibr4-1352458512451944"/><xref ref-type="bibr" rid="bibr5-1352458512451944"/><xref ref-type="bibr" rid="bibr6-1352458512451944"/><xref ref-type="bibr" rid="bibr7-1352458512451944"/><xref ref-type="bibr" rid="bibr8-1352458512451944"/><xref ref-type="bibr" rid="bibr9-1352458512451944"/><xref ref-type="bibr" rid="bibr10-1352458512451944"/><xref ref-type="bibr" rid="bibr11-1352458512451944"/>-12</sup> In more than half of the studies, the criteria of driving ability was performance on computerized tests such as the Useful Field of View (UFOV) test,<sup><xref ref-type="bibr" rid="bibr7-1352458512451944">7</xref>,<xref ref-type="bibr" rid="bibr13-1352458512451944">13</xref></sup> Neurocognitive Driving Test (NDT),<sup><xref ref-type="bibr" rid="bibr7-1352458512451944">7</xref>,<xref ref-type="bibr" rid="bibr13-1352458512451944">13</xref></sup> and in driving simulators,<sup><xref ref-type="bibr" rid="bibr3-1352458512451944">3</xref>,<xref ref-type="bibr" rid="bibr10-1352458512451944">10</xref></sup> or relied on the history of accidents/traffic violations.<sup><xref ref-type="bibr" rid="bibr2-1352458512451944">2</xref>,<xref ref-type="bibr" rid="bibr5-1352458512451944">5</xref>,<xref ref-type="bibr" rid="bibr7-1352458512451944">7</xref>,<xref ref-type="bibr" rid="bibr10-1352458512451944">10</xref></sup> Although the use of the road test outcome as the clinical standard of driving ability remains controversial because of reliability and validity concerns, it is still regarded by many as the closest approximation of real-life driving.<sup><xref ref-type="bibr" rid="bibr13-1352458512451944">13</xref></sup> Only a few studies used performance on a road test as a measure of driving ability of individuals with MS.<sup><xref ref-type="bibr" rid="bibr4-1352458512451944">4</xref>,<xref ref-type="bibr" rid="bibr5-1352458512451944">5</xref>,<xref ref-type="bibr" rid="bibr8-1352458512451944">8</xref>,<xref ref-type="bibr" rid="bibr9-1352458512451944">9</xref></sup> In one of the studies, performance on the Symbol Digit Modality Test only marginally predicted performance on the road test.<sup><xref ref-type="bibr" rid="bibr5-1352458512451944">5</xref></sup> In another study, five tests from an 11-test cognitive battery predicted on-road performance of individuals with MS in the United Kingdom with 88% accuracy.<sup><xref ref-type="bibr" rid="bibr9-1352458512451944">9</xref></sup> However, the five tests are not typically used in the United States of America (US).</p>
<p>In a recent study, the performance of individuals with relapsing–remitting MS in the US on a standardized road test and the UFOV test was predicted with 86% and 84% accuracy, respectively, using performance on the Stroke Driver Screening Assessment (SDSA) battery made up of four cognitive tests.<sup><xref ref-type="bibr" rid="bibr14-1352458512451944">14</xref></sup> Performance on the UFOV test was used as another measure of driving ability because it had been shown to be a reliable and valid predictor of crash risk in older drivers and in different neurological populations.<sup><xref ref-type="bibr" rid="bibr15-1352458512451944">15</xref></sup> However, because our ultimate aim is to find the most accurate predictors of fitness to drive in individuals with MS, we further analyzed the data from the recent study to determine if inclusion of performance on UFOV test and other previously identified cognitive predictors of driving in individuals with MS will improve the accuracy of predicting performance on the road test. Tests of physical functioning and driving-related visual tests such as contrast sensitivity, depth perception, color perception, and glare recovery that are affected in individuals with MS<sup><xref ref-type="bibr" rid="bibr11-1352458512451944">11</xref>,<xref ref-type="bibr" rid="bibr16-1352458512451944">16</xref></sup> were also included in the comprehensive battery. Since we included many more tests that assess a broader variety of functions required to drive safely, we expect that the best model identified in this study will be more accurate (&gt; 86%) in predicting participants’ on-road driving performance than the use of only tests contained in the SDSA battery as in the previous study.<sup><xref ref-type="bibr" rid="bibr14-1352458512451944">14</xref></sup></p>
</sec>
<sec id="section7-1352458512451944" sec-type="methods">
<title>Methods</title>
<p>Data used in this study were from participants who were recruited through the Georgia Health Sciences University (GHSU) Multiple Sclerosis Center. Inclusion criteria were diagnosis of a relapsing–remitting MS verified by neurologists, Expanded Disability Status Scale (EDSS)<sup><xref ref-type="bibr" rid="bibr17-1352458512451944">17</xref></sup> score between 1 and 7, 25–75 years old, with valid driver license, ≥ 5 years’ driving experience, drove at least once a month in the last 1 year, and met minimum legal visual requirements to drive in accordance with Georgia laws (Binocular Visual Acuity ≥ 20/60 and Peripheral Vision ≥ 140 degrees).<sup><xref ref-type="bibr" rid="bibr18-1352458512451944">18</xref></sup> Other inclusion criteria were no substantive cognitive impairment or dementia (≥ 24 in Mini-Mental State Examination),<sup><xref ref-type="bibr" rid="bibr19-1352458512451944">19</xref></sup> on stable medications and dosage (including steroids, benzodiazepines, or other cognition-altering medications), and no exacerbation of symptoms within a month preceding and during the study. Individuals with traumatic brain injury, stroke, Parkinson’s disease, acute psychiatric disorders, drug, and alcohol abuse were excluded.</p>
<sec id="section8-1352458512451944">
<title>Evaluations</title>
<sec id="section9-1352458512451944">
<title>First study visit</title>
<p>Board-certified psychologists administered the Timed 25-Foot Walk, 9-Hole Peg Test (9-HPT), and Paced Auditory Serial Addition Test (PASAT) of the Multiple Sclerosis Functional Composite (MSFC);<sup><xref ref-type="bibr" rid="bibr20-1352458512451944">20</xref></sup> Digit Symbol (DS) and Block Design (BD) from the Wechsler Adult Intelligence Scale-III;<sup><xref ref-type="bibr" rid="bibr21-1352458512451944">21</xref></sup> Stroop Color and Word Test;<sup><xref ref-type="bibr" rid="bibr22-1352458512451944">22</xref></sup> Trail Making Tests A &amp; B (TMT - A &amp; B);<sup><xref ref-type="bibr" rid="bibr23-1352458512451944">23</xref></sup> Hospital Anxiety and Depression Scale (HADS);<sup><xref ref-type="bibr" rid="bibr24-1352458512451944">24</xref></sup> and the 21-item Modified Fatigue Impact Scale (MFIS).<sup><xref ref-type="bibr" rid="bibr25-1352458512451944">25</xref></sup> The first visit typically lasted approximately 2 hours.</p>
</sec>
<sec id="section10-1352458512451944">
<title>Second study visit</title>
<p>Visual tests<sup><xref ref-type="fn" rid="fn1-1352458512451944">a</xref></sup> including contrast sensitivity, depth perception, color perception, and glare recovery as well as cognitive tests including the Rey Osterreith Complex Figure (ROCF),<sup><xref ref-type="bibr" rid="bibr26-1352458512451944">26</xref></sup> and the US version of the SDSA (dot cancellation, directions, compass, road sign recognition (RSR) were administered.<sup><xref ref-type="fn" rid="fn2-1352458512451944">b</xref>,<xref ref-type="bibr" rid="bibr14-1352458512451944">14</xref></sup> The UFOV test was also administered during this visit. The three-subtest (speed of processing, divided attention, and selective attention) computer-based touchscreen version of the UFOV test was used.<sup><xref ref-type="fn" rid="fn3-1352458512451944">c</xref>,<xref ref-type="bibr" rid="bibr27-1352458512451944">27</xref></sup> Performance on the three subtests was automatically calculated by the test software to generate overall performance on the UFOV test in one of five classes, with 1 meaning very low risk and 5 meaning very high risk for accident. Categories 1 and 2 were further classified as ‘Pass’ while categories 3, 4, or 5, were classified ‘Fail’.<sup><xref ref-type="bibr" rid="bibr15-1352458512451944">15</xref></sup> The second visit typically lasted approximately 2 hours as well</p>
</sec>
<sec id="section11-1352458512451944">
<title>Third study visit</title>
<p>During this visit, each participant’s performance on a standardized road test (outcome measure) was evaluated in a vehicle with automatic transmission, adapted for safety (dual controls), and registered with the Georgia Department of Driver Services. The road test course, which is the same as the course used for licensing novice and older drivers, traversed rural, urban, and interstate roadways and took approximately 45 min to complete. The test was administered by a certified driving instructor with over 33 years of experience in the assessment of older, disabled, and novice drivers. During the test, the instructor made short notes with which a 16-item checklist was completed immediately after the test. The checklist consisted of 10 general driving behavior items (approaching traffic signs, checking blind spots, speeding, braking, lane keeping, lane changing, staying in center of lane, following, signaling, and right of way) and the accuracy of execution of three left and three right turns. A maximum score of 50 points was obtainable on the road test. A score of 45 or more out of a maximum of 50 points on the road test was classified as ‘Pass’ (no major concerns) and others as ‘Fail’ (concerns with some aspects of driving), as is done during the real-life evaluation of individuals who have experienced a neurological condition such as stroke, Parkinson’s disease, and MS at the GHSU Driving Evaluation and Training facility.</p>
<p>Each participant’s three study visits took place within 2 weeks and all test administrators were blinded to performance on all other tests not administered by them. Consent process and all study protocols were approved by the institutional Human Assurance Committee.</p>
</sec>
</sec>
<sec id="section12-1352458512451944">
<title>Data analysis</title>
<p>Demographic, clinical, and visual variables of participants who passed the road test were compared with those of participants who failed the test. The appropriate comparative statistics to use were determined following normality testing using the Kolmogorov–Smirnov test. The association between the demographic, clinical, and visual variables (predictors) and the main outcome variable, i.e. the raw scores on the road test were obtained by Pearson (<italic>r</italic>), biserial (<italic>rb</italic>), or spearman rho (<italic>rs</italic>) correlations, as appropriate. Correlations were considered to be weak below 0.30, moderate between 0.30 and 0.69 and high between 0.70 and 1.00.<sup><xref ref-type="bibr" rid="bibr28-1352458512451944">28</xref></sup> The variables that correlated at least moderately (<italic>r</italic> &gt; 0.30) with the outcome variable were examined for intercolinearity using an a priori defined critical value of <italic>r</italic> ≥ 0.60. From each pair of highly intercorrelated variables, the variable with the better association with the outcome variable was entered in the multivariate regression analyses. The model that explained the highest variance in the raw scores on the road test was identified using multiple regression analysis. Variables contained in the model were entered into a discriminant analysis to obtain the discriminant equations that best predict the ‘Pass’ or ‘Fail’ performance on the road test.</p>
<p>All statistical analyses were performed using SAS<sup><xref ref-type="bibr" rid="bibr29-1352458512451944">29</xref></sup> and a <italic>p</italic>-value ≤ 0.05 was used in all cases of significance testing.</p>
</sec>
</sec>
<sec id="section13-1352458512451944" sec-type="results">
<title>Results</title>
<p>Over a period of 13 months, 50 consecutive patients with diagnosis of a relapsing–remitting MS who attended the GHSU Multiple Sclerosis Center and met all study criteria were recruited into the study. Only 49 of them were evaluated at the GHSU driving laboratory because one participant chose not to continue in the study after giving consent. Before the road test, one participant relapsed and four opted out of the study out of concern about the potential legal implication of failing the road test despite being informed during consenting of no such implication. Explorative data analysis showed that the demographic and clinical characteristics of the four participants were not different from those of the 44 participants (age = 46 ± 11 years, 37 females, median duration of MS = 6.5 years, and median EDSS = 3) whose data were further analyzed.</p>
<p>All demographic, most clinical and most visual variables were not different between participants who passed (<italic>n</italic> = 34) and those who failed (<italic>n</italic> = 10) the road test (<xref ref-type="table" rid="table1-1352458512451944">Table 1</xref>). Participants who passed the road test performed better than those who failed on average time to complete the 9-HPT (<italic>p</italic> = 0.04), number of correctly identified stimuli on the PASAT (<italic>p</italic> = 0.003), and had no false positive mistakes on the dot cancellation test (<italic>p</italic> = 0.04), performed better on the compass (<italic>p</italic> = 0.002), and RSR (<italic>p</italic> = 0.009) tests of the SDSA. Participants who passed the road test also had faster speed of processing visual information (<italic>p</italic> = 0.003) and better divided (<italic>p</italic> = 0.008) and selective attention skills (<italic>p</italic> = 0.006) on the UFOV test and had less difficulty with identifying blue and violet-colored visual stimuli (<italic>p</italic> = 0.03) when compared with those who failed the road test.</p>
<table-wrap id="table1-1352458512451944" position="float">
<label>Table 1.</label>
<caption><p>Demographic, clinical, and visual characteristics of participants who passed or failed on the road test.</p></caption>
<graphic alternate-form-of="table1-1352458512451944" xlink:href="10.1177_1352458512451944-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Variable</th>
<th align="left">Pass <italic>N</italic> = 34</th>
<th align="left">Fail <italic>N</italic> = 10</th>
<th align="left">Test statistic</th>
<th align="left"><italic>p</italic>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="5"><bold><italic>Demographic</italic></bold></td>
</tr>
<tr>
<td>Age, y (mean ± SD)</td>
<td>45.5 ± 11.1</td>
<td>45.1 ± 11.4</td>
<td>t = −0.14</td>
<td>0.89</td>
</tr>
<tr>
<td>Sex, (male/female)</td>
<td>6/28</td>
<td>1/9</td>
<td>F = 0.35</td>
<td>1.00</td>
</tr>
<tr>
<td>Education, y (med., Q1–Q3)</td>
<td>12 (12–15)</td>
<td>12 (12-12)</td>
<td>W = 219</td>
<td>0.86</td>
</tr>
<tr>
<td>Driving experience, y (med., Q1–Q3)</td>
<td>28 (19–36)</td>
<td>30 (25–36)</td>
<td>W = 230</td>
<td>0.91</td>
</tr>
<tr>
<td>Mileage, 10<sup>3</sup>; miles (med., Q1–Q3)</td>
<td>12 (8–15)</td>
<td>10 (6–12)</td>
<td>W = 167</td>
<td>0.11</td>
</tr>
<tr>
<td>Daily, miles (med., Q1–Q3)</td>
<td>30 (10–40)</td>
<td>20 (15–30)</td>
<td>W = 197</td>
<td>0.43</td>
</tr>
<tr>
<td colspan="5"><bold><italic>Clinical</italic></bold></td>
</tr>
<tr>
<td>Duration of MS, y (med., Q1–Q3)</td>
<td>6.5 (5–13)</td>
<td>3 (2–7)</td>
<td>W = 165</td>
<td>0.10</td>
</tr>
<tr>
<td>EDSS, /10 (med., Q1–Q3)</td>
<td>3 (2–4)</td>
<td>3 (2–6)</td>
<td>W = 237</td>
<td>0.75</td>
</tr>
<tr>
<td>Barthel Index, /100 (med., Q1–Q3)</td>
<td>100 (95–100)</td>
<td>97.5 (95–100)</td>
<td>W = 205</td>
<td>0.52</td>
</tr>
<tr>
<td>MMSE, /30 (med., Q1–Q3)</td>
<td>30 (29–30)</td>
<td>29.5 (29–30)</td>
<td>W = 196</td>
<td>0.35</td>
</tr>
<tr>
<td>MSFC composite (mean ± SD)</td>
<td>23. 9 ± 3.4</td>
<td>22.0 ± 3.1</td>
<td>t = 1.52</td>
<td>0.14</td>
</tr>
<tr>
<td>25-Foot Walk, sec (mean ± SD)</td>
<td>5.7 ± 1.9</td>
<td>6.8 ±2.0</td>
<td>t = −1.57</td>
<td>0.13</td>
</tr>
<tr>
<td>9-Hole Peg, sec (med., Q1–Q3)</td>
<td>21.4 (20.2–24.5)</td>
<td>26.4 (21.4–29.9)</td>
<td>W = 301</td>
<td><bold>0.04</bold></td>
</tr>
<tr>
<td>PASAT, (mean ± SD)</td>
<td>43.09 ± 10.33</td>
<td>29.70 ±15.37</td>
<td>t = 3.21</td>
<td><bold>0.003</bold></td>
</tr>
<tr>
<td>DS, sec (med., Q1–Q3)</td>
<td>7 (5–10)</td>
<td>7.5 (3–10)</td>
<td>W = 209</td>
<td>0.65</td>
</tr>
<tr>
<td>BD, sec (med., Q1–Q3)</td>
<td>9 (8–10)</td>
<td>7.5 (7–9)</td>
<td>W = 168</td>
<td>0.11</td>
</tr>
<tr>
<td>Stroop color, sec (med., Q1–Q3)</td>
<td>11.9 (11.0 – 14.0)</td>
<td>14.3 (12.5 – 16.0)</td>
<td>W = 268</td>
<td>0.12</td>
</tr>
<tr>
<td>Stroop word, sec (med., Q1–Q3)</td>
<td>16.2 (13.8 – 19.0)</td>
<td>16.3 (15.0 – 22.2)</td>
<td>W = 255</td>
<td>0.20</td>
</tr>
<tr>
<td>Stroop color-word, sec (med., Q1–Q3)</td>
<td>26.5 (21.8 – 30.0)</td>
<td>29.0 (20.0 – 32.1)</td>
<td>W = 240</td>
<td>0.35</td>
</tr>
<tr>
<td>TMT-A, sec (mean ± SD)</td>
<td>32.0 ± 8.5</td>
<td>37.3 ± 16.1</td>
<td>t = −1.00</td>
<td>0.34</td>
</tr>
<tr>
<td>TMT-B, sec (med., Q1–Q3)</td>
<td>70 (52–79)</td>
<td>114.5 (56–176)</td>
<td>W = 290</td>
<td>0.08</td>
</tr>
<tr>
<td>HADS anxiety, /21 (med., Q1–Q3)</td>
<td>8 (4–11)</td>
<td>9 (5–11)</td>
<td>W = 238</td>
<td>0.71</td>
</tr>
<tr>
<td>HADS depression, /21 (med., Q1–Q3)</td>
<td>4.5 (2 -8)</td>
<td>9 (4–11)</td>
<td>W = 290</td>
<td>0.08</td>
</tr>
<tr>
<td>MFIS composite, (mean ± SD)</td>
<td>43.15 ± 18.58</td>
<td>47 ± 13.67</td>
<td>t = −0.61</td>
<td>0.55</td>
</tr>
<tr>
<td>ROCF, / 36 (med., Q1–Q3)</td>
<td>36 (35–36)</td>
<td>36 (34–36)</td>
<td>W = 203</td>
<td>0.47</td>
</tr>
<tr>
<td>SDSA dot cancel time, sec (med., Q1–Q3)</td>
<td>443 (395–659)</td>
<td>537 (410–628)</td>
<td>W = 239</td>
<td>0.72</td>
</tr>
<tr>
<td>SDSA dot cancel errors, <italic>n</italic> (med., Q1–Q3)</td>
<td>2 (1–9)</td>
<td>8 (3–18)</td>
<td>W = 289</td>
<td>0.08</td>
</tr>
<tr>
<td>SDSA dot cancel false positive, n (med., Q1–Q3)</td>
<td>0 (0–0)</td>
<td>0 (0–1)</td>
<td>W = 267</td>
<td><bold>0.04</bold></td>
</tr>
<tr>
<td>SDSA directions, <italic>n</italic> (med., Q1–Q3)</td>
<td>32 (32–32)</td>
<td>32 (28–32)</td>
<td>W = 183</td>
<td>0.07</td>
</tr>
<tr>
<td>SDSA compass, <italic>n</italic> (med., Q1–Q3)</td>
<td>30.50 (22–32)</td>
<td>15.5 (13–20)</td>
<td>W = 113</td>
<td><bold>0.002</bold></td>
</tr>
<tr>
<td>SDSA road sign recognition, <italic>n</italic> (med., Q1–Q3)</td>
<td>9 (8–12)</td>
<td>6 (4–8)</td>
<td>W = 128</td>
<td><bold>0.009</bold></td>
</tr>
<tr>
<td>UFOV processing speed, msec (med., Q1–Q3)</td>
<td>17 (17–17)</td>
<td>53.4 (17–87)</td>
<td>W = 323</td>
<td><bold>0.003</bold></td>
</tr>
<tr>
<td>UFOV divided attention, msec (med., Q1–Q3)</td>
<td>19 (17–47)</td>
<td>202 (37–500)</td>
<td>W = 322</td>
<td><bold>0.008</bold></td>
</tr>
<tr>
<td>UFOV selective attention, msec (med., Q1–Q3)</td>
<td>158 (113–243)</td>
<td>335 (277–500)</td>
<td>W = 329</td>
<td><bold>0.006</bold></td>
</tr>
<tr>
<td colspan="5"><bold><italic>Visual</italic></bold></td>
</tr>
<tr>
<td>Contrast sensitivity, <italic>n</italic> (normal/impaired)</td>
<td>33/1</td>
<td>9/1</td>
<td>F = 0.36</td>
<td>0.41</td>
</tr>
<tr>
<td>Glare recovery, <italic>n</italic> (normal/impaired)</td>
<td>28/6</td>
<td>6/4</td>
<td>F = 0.12</td>
<td>0.20</td>
</tr>
<tr>
<td>Depth perception, <italic>n</italic> (normal/impaired)</td>
<td>7/27</td>
<td>1/9</td>
<td>F = 0.30</td>
<td>0.66</td>
</tr>
<tr>
<td>Red &amp; Green color perception, <italic>n</italic> (normal/impaired)</td>
<td>24/10</td>
<td>4/6</td>
<td>F = 0.06</td>
<td>0.13</td>
</tr>
<tr>
<td>Blue &amp; Violet color perception, <italic>n</italic> (normal/impaired)</td>
<td>33/1</td>
<td>7/3</td>
<td>F = 0.03</td>
<td><bold>0.03</bold></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1352458512451944">
<p>Abbreviation: t = unpaired <italic>t</italic>-test; W = Wilcoxon rank sum test; F = Fishers Exact; EDSS = Expanded Disability Status Scale; MMSE = Mini-Mental State Examination; MSFC = Multiple Sclerosis Functional Composite; PASAT = Paced Auditory Serial Addition Test; DS =Digit Symbol; BD = Block Design; TMT = Trail Making Test; HADS = Hospital Anxiety and Depression Scale; MFIS = Modified Fatigue Impact Scale; ROCF = Rey Osterreith Complex Figure; SDSA = Stroke Driver Screening Assessment, UFOV = Useful Field of View</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Outcome of the correlation analyses revealed that all 44 participants’ performance (in order of increasing magnitude of <italic>r</italic>) on cognitive tests including the 9-HPT, BD, UFOV-speed of processing, Stroop word test, TMT-A, SDSA-compass, UFOV-selective attention, SDSA-directions, Stroop color test, PASAT, and SDSA-RSR as well as on visual tests including recovery from glare, blue and violet color perception, and contrast sensitivity were moderately (<italic>r</italic> = 0.31–0.63) associated (<italic>p</italic> = 0.05 to <italic>p</italic> ≤ 0.0001) with performance on the road test. The pairs of UFOV-selective attention versus PASAT (<italic>r</italic> = 0.62, <italic>p</italic> ≤ 0.0001), Stroop color versus Stroop word (<italic>r</italic> = 0.62, <italic>p</italic> ≤ 0.0001), contrast sensitivity versus Stroop color (<italic>r</italic> = 0.63, <italic>p</italic> = &lt; 0.0001), SDSA-direction versus TMT-A (<italic>r</italic> = 0.65, <italic>p</italic> ≤ 0.0001), UFOV-selective attention versus SDSA-compass (<italic>r</italic> = 0.73, <italic>p</italic> ≤ 0.0001) and SDSA-RSR versus PASAT (<italic>r</italic> = 0.75, <italic>p</italic> ≤ 0.0001) exceeded the a priori defined value of 0.60. Based on individual associations with performance on the road test, only the direction and RSR tests of the SDSA and Stroop color tests among the intercorrelated pairs were added to the other tests with individual associations with the road test for the stepwise multiple regression analysis.</p>
<p>A model containing the time to complete the Stroop color test, the directions, compass, and RSR tests of the SDSA and the UFOV-speed of processing test (<xref ref-type="table" rid="table2-1352458512451944">Table 2</xref>) explained the highest variance (<italic>R</italic><sup>2</sup> = 0.59) of performance on the road test.</p>
<table-wrap id="table2-1352458512451944" position="float">
<label>Table 2.</label>
<caption>
<p>Model that best predicted performance on the road test using multiple regression.</p></caption>
<graphic alternate-form-of="table2-1352458512451944" xlink:href="10.1177_1352458512451944-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="center"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Variable</th>
<th align="left">DF</th>
<th align="left">Parameter Estimate</th>
<th align="left">Standard Error</th>
<th align="left"><italic>t</italic>-value</th>
<th align="left"><italic>p</italic>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td>Intercept</td>
<td>1</td>
<td>42.0205</td>
<td>2.99796</td>
<td>14.02</td>
<td>&lt; 0.0001</td>
</tr>
<tr>
<td>Stroop color</td>
<td>1</td>
<td>−0.21497</td>
<td>0.08229</td>
<td>−2.61</td>
<td>0.0128</td>
</tr>
<tr>
<td>Direction</td>
<td>1</td>
<td>0.09757</td>
<td>0.07916</td>
<td>1.23</td>
<td>0.2253</td>
</tr>
<tr>
<td>Compass</td>
<td>1</td>
<td>0.05099</td>
<td>0.05738</td>
<td>0.89</td>
<td>0.3798</td>
</tr>
<tr>
<td>Road Sign Recognition</td>
<td>1</td>
<td>0.32450</td>
<td>0.16360</td>
<td>1.98</td>
<td>0.0546</td>
</tr>
<tr>
<td>UFOV – speed of processing</td>
<td>1</td>
<td>−0.01093</td>
<td>0.00772</td>
<td>−1.42</td>
<td>0.1650</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-1352458512451944">
<p><italic>R</italic>-Square = 0.59</p>
</fn>
<fn id="table-fn3-1352458512451944">
<p>Abbreviation: UFOV = Useful Field of View</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The discriminant equation based on performance on all five tests is presented below.</p>
<table-wrap id="table4-1352458512451944" position="float">
<graphic alternate-form-of="table4-1352458512451944" xlink:href="10.1177_1352458512451944-table4.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
</colgroup>
<tbody>
<tr>
<td><bold><italic>Pass</italic></bold></td>
<td>(Stroop color *1.7250) + (SDSA-direction*1.6991) + (SDSA-compass*0.0123) + (SDSA-RSR*1.5713) + (UFOV-speed of processing*0.0125) - 45.4587</td>
</tr>
<tr>
<td><bold><italic>Fail</italic></bold></td>
<td>(Stroop color *1.8028) + (SDSA-direction*1.6238) + (SDSA-compass*-0.1528) + (SDSA-RSR*1.3667) + (UFOV-speed of processing*0.0417) - 40.5235</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>When a participant’s ‘Pass’ score is higher than the ‘Fail’ score, that individual is predicted to pass, and vice versa. Using this equation, participants’ ‘Pass’ or ‘Fail’ performance on the road test was predicted with 91% accuracy, 70% sensitivity, and 97% specificity (<xref ref-type="table" rid="table3-1352458512451944">Table 3</xref>). The positive predictive value (PPV) of the prediction was 88% and the negative predictive value (NPV) was 92%.</p>
<table-wrap id="table3-1352458512451944" position="float">
<label>Table 3.</label>
<caption><p>Predicted versus actual performance on the road test.</p></caption>
<graphic alternate-form-of="table3-1352458512451944" xlink:href="10.1177_1352458512451944-table3.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="left" colspan="2"><bold>Road</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td><bold>Predicted</bold></td>
<td>Fail</td>
<td>Pass</td>
</tr>
<tr>
<td>Fail</td>
<td>7</td>
<td>1</td>
</tr>
<tr>
<td>Pass</td>
<td>3</td>
<td>33</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn4-1352458512451944">
<p>Predictive accuracy = (7+33) / (7 + 1 + 3 + 33) = 91%</p>
</fn>
<fn id="table-fn5-1352458512451944">
<p>Sensitivity = (7) / (7 + 3) = 70%</p>
</fn>
<fn id="table-fn6-1352458512451944">
<p>Specificity = (33) / (1 + 33) = 97%</p>
</fn>
<fn id="table-fn7-1352458512451944">
<p>Positive Predictive Value = (7) / (7 + 1) = 88%</p>
</fn>
<fn id="table-fn8-1352458512451944">
<p>Negative Predictive Value = (33) / (3 + 33) = 92%</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section14-1352458512451944" sec-type="discussion">
<title>Discussion</title>
<p>Only performance in two of the three component tests of the MSFC, most of the tests of the SDSA, all three components of the UFOV test, and the visual test of blue and violet color perception distinguished between particpants who passed versus those who failed the road test. However, a greater number of the cognitive and visual tests were individually significantly associated with performance on the road test. This finding is not surprising since all the tests were included based on previously reported relationship with driving in individuals with MS. Tests related to physical fuctioning including the Barthel index, EDSS, and MSFC-Timed 25-Foot Walk test and the MFIS were not significantly associated with performance on the road test. This finding is in line with evidence in previous studies that driving ability is typically affected by the cognitive and visual deficits commonly experienced after a neurological condition such as MS,<sup><xref ref-type="bibr" rid="bibr11-1352458512451944">11</xref>,<xref ref-type="bibr" rid="bibr16-1352458512451944">16</xref></sup> stroke,<sup><xref ref-type="bibr" rid="bibr30-1352458512451944">30</xref></sup> Parkinson’s disease,<sup><xref ref-type="bibr" rid="bibr31-1352458512451944">31</xref></sup> and dementia.<sup><xref ref-type="bibr" rid="bibr32-1352458512451944">32</xref></sup></p>
<p>The addition of of other driving-related physical, visual, and cognitive tests to performance on the SDSA tests resulted in a more accurate (91%) prediction of particpants’ on-road driving performance than using only performance in the tests of the SDSA (86%).<sup><xref ref-type="bibr" rid="bibr14-1352458512451944">14</xref></sup> A combination of time to complete the Stroop color test, speed of processing visual information of the UFOV test, and three tests of the SDSA (direction, compass and RSR) together explained 59% of the variance. Although only the color subtest of the Stroop Color and Word Test is included in the most predictive model, both the color and the word subtests were individually significantly associated with performance on the road test. The Stroop Color and Word Test is a test of cognitive flexibility and resistance to external interference that is simple and quick to administer with established reliability and validity.<sup><xref ref-type="bibr" rid="bibr33-1352458512451944">33</xref></sup> Performance on the test discriminated between cognitively impaired versus non-cognitively impaired individuals with MS in another driving-related study.<sup><xref ref-type="bibr" rid="bibr2-1352458512451944">2</xref></sup> The speed of processing visual information, one of the predictors included in the model in this study, has been reported in several studies as a very important predictor of crash risk in older drivers,<sup><xref ref-type="bibr" rid="bibr34-1352458512451944">34</xref></sup> some neurological conditions,<sup><xref ref-type="bibr" rid="bibr35-1352458512451944">35</xref></sup> and in individuals with MS.<sup><xref ref-type="bibr" rid="bibr5-1352458512451944">5</xref>,<xref ref-type="bibr" rid="bibr7-1352458512451944">7</xref></sup> It is estimated that more than 90% of the sensory imput required to drive is visual related.<sup><xref ref-type="bibr" rid="bibr36-1352458512451944">36</xref></sup> As a result, it is understandable why the ability to process multiple visual stimuli in good time during the performance of a higly dynamic and time-dependent activity like driving is important. It is not surprising to us that three of the four components of the test were retained in the most predictive model identified in this study. The SDSA, a test of executive function and reasoning skills that are very crucial in driving, has been shown several times to be predictive of on-road performance of individuals with stroke,<sup><xref ref-type="bibr" rid="bibr30-1352458512451944">30</xref>,<xref ref-type="bibr" rid="bibr37-1352458512451944">37</xref></sup> Parkinson’s disease,<sup><xref ref-type="bibr" rid="bibr31-1352458512451944">31</xref>,<xref ref-type="bibr" rid="bibr38-1352458512451944">38</xref></sup> traumatic brain injury,<sup><xref ref-type="bibr" rid="bibr39-1352458512451944">39</xref></sup> dementia,<sup><xref ref-type="bibr" rid="bibr32-1352458512451944">32</xref></sup> and MS.<sup><xref ref-type="bibr" rid="bibr13-1352458512451944">13</xref></sup> However, in spite of its reported relevance in predicting driving after different neurological conditions, the SDSA was never used in the US. The earlier study<sup><xref ref-type="bibr" rid="bibr14-1352458512451944">14</xref></sup> and this one are the only studies so far to have used and reported on the usefulness of the SDSA in predicting fitness to drive of a US-based population of individuals with relapsing– remitting MS.</p>
<p>The five tests contained in the best model identified in this study can together be administered in less than 45 min, should cost no more than $150, and is 91% accurate in detecting if an individual with relapsing–remitting MS is fit to drive or not. Predictions based on the tests are expected to be nearly perfectly accurate (97% specificity) in correctly identifying those who are fit to drive. A very high specficity, also reported in similar studies,<sup><xref ref-type="bibr" rid="bibr5-1352458512451944">5</xref>,<xref ref-type="bibr" rid="bibr14-1352458512451944">14</xref></sup> is desired in a process involving the determination of continued participation in an activity that is risk-involved such as driving. With a PPV of 88%, anyone predicted to be unfit to drive using performance in the five tests does have only a 12% chance of performing well on a road test. Further data exploration revealed that the difference between the ‘Pass’ and ‘Fail’ scores (derived from the discriminant equation) of the four participants who were wrongly predicted to either fail but passed (<italic>n</italic> = 1) or pass but failed (<italic>n</italic> = 3) the road test was less than 2. It is likely that the participant predicted to fail but passed adequately compensated for the deficits in the off-road tests during the on-road test. It is also likely that the five off-road tests were not sensitive enough to correctly detect the driving skills of the three participants predicted to pass but failed. As a result, we recommend that performance on the five psychometric/off-road tests should, at best, be used as a short, quick, and accurate screening tool to identify individuals with relapsing–remitting MS who could proceed to perform a standardized road test to finally decide their fitness to drive (‘Pass’ value higher than ‘Fail’ value by &gt; 2) versus those who need to be further evaluated using an extended battery of tests. Considering current practices in many driving evaluation centers across the US in which MS patients are administered an extended battery of tests, which take between 2–3 hours to complete, and cost on average between $300–450, the major finding in this study is highly clinically relevant.</p>
<p>Study limitations including sample size, lack of an independent sample to validate study findings, and the inability to generalize study findings other types of MS patients besides those with relapsing–remitting MS. Only individuals with relapsing–remitting MS were included in this preliminary study because it is the most common form of MS and they constitute the majority of individuals with MS who continue to drive.<sup><xref ref-type="bibr" rid="bibr5-1352458512451944">5</xref></sup> Yet, when compared with the 2009 national statistics on number of discharges from hospitals of patients who had a diagnosis of MS,<sup><xref ref-type="bibr" rid="bibr40-1352458512451944">40</xref></sup> the mean age and gender distribution of our study cohort can be said to be representative of MS population in the US. Our future plan is to conduct a larger study including different types of MS and an independent sample to confirm and validate the predictive accuracy of the model found in this study.</p>
</sec>
</body>
<back>
<notes>
<label>Notes on equipment</label>
<fn-group>
<fn fn-type="other" id="fn1-1352458512451944">
<label>a.</label>
<p>Vision Screening with the VS-V GT Medical Vision Screener. Available at: <ext-link ext-link-type="uri" xlink:href="http://www.keystoneview.com">http://www.keystoneview.com</ext-link> (last accessed last accessed 01/16/2012).</p></fn>
<fn fn-type="other" id="fn2-1352458512451944">
<label>b.</label>
<p>SDSA: Available at: <ext-link ext-link-type="uri" xlink:href="http://www.nottingham.ac.uk/IWHO/Research/PublishedAssessments.aspx">http://www.nottingham.ac.uk/IWHO/Research/PublishedAssessments.aspx</ext-link> (last accessed last accessed 01/16/2012).</p></fn>
<fn fn-type="other" id="fn3-1352458512451944">
<label>c.</label>
<p>UFOV: Available at: <ext-link ext-link-type="uri" xlink:href="http://www.visualawareness.com/Pages/whatis.html">http://www.visualawareness.com/Pages/whatis.html</ext-link> (last accessed last accessed 01/16/2012).</p></fn>
</fn-group>
</notes>
<ack>
<p>The authors acknowledge the contributions of Sola Fasusi, MD, Kate Viner, PhD, Kelly Baker, BS, Michelle Hoogstra, BS, Erin McGonegal, BS, Christina O’Connor, BS, Kendra Philips, BS, Kristen Turchi, BS, and Crystal Stargell, BS during data acquisition. Hannes Devos is a postdoctoral fellow of the Research Foundation – Flanders. Biostatistical analysis was carried out by AE Akinwuntan and H Devos.</p>
</ack>
<fn-group>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>This study was supported by a grant from the Consortium of Multiple Sclerosis Centers.</p>
</fn>
<fn fn-type="conflict">
<label>Conflict of interest</label>
<p>The authors declare that they have no conflicts of interest.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1352458512451944">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lings</surname><given-names>S</given-names></name>
</person-group>. <article-title>Driving accident frequency increased in patients with multiple sclerosis</article-title>. <source>Acta Neurol Scand</source> <year>2002</year>; <volume>105</volume>: <fpage>169</fpage>–<lpage>173</lpage>.</citation>
</ref>
<ref id="bibr2-1352458512451944">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schultheis</surname><given-names>MT</given-names></name>
<name><surname>Garay</surname><given-names>E</given-names></name>
<name><surname>Millis</surname><given-names>SR</given-names></name>
<etal/>
</person-group>. <article-title>Motor vehicle crashes and violations among drivers with multiple sclerosis</article-title>. <source>Arch Phys Med Rehab</source> <year>2002</year>; <volume>83</volume>: <fpage>1175</fpage>–<lpage>1178</lpage>.</citation>
</ref>
<ref id="bibr3-1352458512451944">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kotterba</surname><given-names>S</given-names></name>
<name><surname>Orth</surname><given-names>M</given-names></name>
<name><surname>Eren</surname><given-names>E</given-names></name>
<etal/>
</person-group>. <article-title>Assessment of driving performance in patients with relapsing–remitting multiple sclerosis by a driving simulator</article-title>. <source>Eur J of Neurol</source> <year>2003</year>; <volume>50</volume>: <fpage>160</fpage>–<lpage>164</lpage>.</citation>
</ref>
<ref id="bibr4-1352458512451944">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schultheis</surname><given-names>MT</given-names></name>
<name><surname>Weisser</surname><given-names>V</given-names></name>
<name><surname>Manning</surname><given-names>K</given-names></name>
<etal/>
</person-group>. <article-title>Driving behaviors among community-dwelling persons with multiple sclerosis</article-title>. <source>Arch Phys Med Rehab</source> <year>2009</year>; <volume>90</volume>: <fpage>95</fpage>–<lpage>981</lpage>.</citation>
</ref>
<ref id="bibr5-1352458512451944">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schultheis</surname><given-names>MT</given-names></name>
<name><surname>Weisser</surname><given-names>V</given-names></name>
<name><surname>Ang</surname><given-names>J</given-names></name>
<etal/>
</person-group>. <article-title>Examining the relationship between cognition and driving performance in multiple sclerosis</article-title>. <source>Arch Phys Med Rehab</source> <year>2010</year>; <volume>91</volume>: <fpage>465</fpage>–<lpage>473</lpage>.</citation>
</ref>
<ref id="bibr6-1352458512451944">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schultheis</surname><given-names>MT</given-names></name>
<name><surname>Garay</surname><given-names>E</given-names></name>
<name><surname>DeLuca</surname><given-names>J</given-names></name>
</person-group>. <article-title>The influence of cognitive impairment on driving performance in multiple sclerosis</article-title>. <source>Neurology</source> <year>2001</year>; <volume>56</volume>: <fpage>1089</fpage>–<lpage>1094</lpage>.</citation>
</ref>
<ref id="bibr7-1352458512451944">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shawaryn</surname><given-names>MA</given-names></name>
<name><surname>Schultheis</surname><given-names>MT</given-names></name>
<name><surname>Garay</surname><given-names>E</given-names></name>
<etal/>
</person-group>. <article-title>Assessing functional status: exploring the relationship between the Multiple Sclerosis Functional Composite and driving</article-title>. <source>Arch Phys Med Rehab</source> <year>2002</year>; <volume>83</volume>: <fpage>1123</fpage>–<lpage>1129</lpage>.</citation>
</ref>
<ref id="bibr8-1352458512451944">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schanke</surname><given-names>AK</given-names></name>
<name><surname>Sundet</surname><given-names>K</given-names></name>
</person-group>. <article-title>Comprehensive driving assessment: neuropsychological testing and on-road evaluation of brain injured patients</article-title>. <source>Scand J Psychol</source> <year>2000</year>; <volume>41</volume>: <fpage>113</fpage>–<lpage>121</lpage>.</citation>
</ref>
<ref id="bibr9-1352458512451944">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lincoln</surname><given-names>NB</given-names></name>
<name><surname>Radford</surname><given-names>KA</given-names></name>
</person-group>. <article-title>Cognitive abilities as predictors of safety to drive in people with multiple sclerosis:</article-title> <source>Mult Scler</source> <year>2008</year>; <volume>14</volume>: <fpage>123</fpage>–<lpage>128</lpage>.</citation>
</ref>
<ref id="bibr10-1352458512451944">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Marcotte</surname><given-names>TD</given-names></name>
<name><surname>Rosenthal</surname><given-names>TJ</given-names></name>
<name><surname>Roberts</surname><given-names>E</given-names></name>
<etal/>
</person-group>. <article-title>The contribution of cognition and spasticity to driving performance in multiple sclerosis</article-title>. <source>Arch Phys Med Rehab</source> <year>2008</year>; <volume>89</volume>: <fpage>1753</fpage>–<lpage>1758</lpage>.</citation>
</ref>
<ref id="bibr11-1352458512451944">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schultheis</surname><given-names>MT</given-names></name>
<name><surname>Manning</surname><given-names>K</given-names></name>
<name><surname>Weisser</surname><given-names>V</given-names></name>
<etal/>
</person-group>. <article-title>Vision and driving in multiple sclerosis</article-title>. <source>Arch Phys Med Rehab</source> <year>2010</year>; <volume>91</volume>: <fpage>315</fpage>–<lpage>317</lpage>.</citation>
</ref>
<ref id="bibr12-1352458512451944">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chipchase</surname><given-names>SY</given-names></name>
<name><surname>Lincoln</surname><given-names>NB</given-names></name>
<name><surname>Radford</surname><given-names>KA</given-names></name>
</person-group>. <article-title>A survey of the effects of fatigue on driving in people with multiple sclerosis</article-title>. <source>Disabil Rehabil</source> <year>2003</year>; <volume>25</volume>: <fpage>712</fpage>–<lpage>721</lpage>.</citation>
</ref>
<ref id="bibr13-1352458512451944">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Korner-Bitensky</surname><given-names>N</given-names></name>
<name><surname>Bitensky</surname><given-names>J</given-names></name>
<name><surname>Sofer</surname><given-names>S</given-names></name>
<etal/>
</person-group>. <article-title>Driving evaluation practices of clinicians working in the United States and Canada</article-title>. <source>Am J Occup Ther</source> <year>2006</year>; <volume>60</volume>: <fpage>428</fpage>–<lpage>434</lpage>.</citation>
</ref>
<ref id="bibr14-1352458512451944">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Akinwuntan</surname><given-names>AE</given-names></name>
<name><surname>O’Connor</surname><given-names>C</given-names></name>
<name><surname>McGonegal</surname><given-names>E</given-names></name>
<etal/>
</person-group>. <article-title>Stroke Driver Screening Assessment predicts driving in individuals with multiple sclerosis</article-title>. <source>Int J Mult Scler</source> <year>2012</year>; <comment>In press</comment>.</citation>
</ref>
<ref id="bibr15-1352458512451944">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>George</surname><given-names>S</given-names></name>
<name><surname>Crotty</surname><given-names>M</given-names></name>
</person-group>. <article-title>Establishing criterion validity of the Useful Field of View assessment and Stroke Driver’s Screening Assessment: comparison to the results of on-road assessment</article-title>. <source>Am J Occup Ther</source> <year>2010</year>; <volume>64</volume>: <fpage>114</fpage>–<lpage>122</lpage>.</citation>
</ref>
<ref id="bibr16-1352458512451944">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Travis</surname><given-names>D</given-names></name>
<name><surname>Thompson</surname><given-names>P</given-names></name>
</person-group>. <article-title>Spatiotemporal contrast sensitivity and color vision in multiple sclerosis</article-title>. <source>Brain</source> <year>1989</year>; <volume>112</volume>: <fpage>283</fpage>–<lpage>303</lpage>.</citation>
</ref>
<ref id="bibr17-1352458512451944">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kurtzke</surname><given-names>JF</given-names></name>
</person-group>. <article-title>Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)</article-title>. <source>Neurology</source> <year>1983</year>; <volume>33</volume>: <fpage>1444</fpage>–<lpage>1452</lpage>.</citation>
</ref>
<ref id="bibr18-1352458512451944">
<label>18.</label>
<citation citation-type="gov">
<comment>State of Georgia, USA Licensing Requirements</comment>: <comment>Available at: <ext-link ext-link-type="uri" xlink:href="http://www.nhtsa.dot.gov/people/injury/olddrive/OlderDriversBook/pages/Georgia.htm">http://www.nhtsa.dot.gov/people/injury/olddrive/OlderDriversBook/pages/Georgia.htm</ext-link></comment> (<access-date>last accessed 01/16/2012</access-date>).</citation>
</ref>
<ref id="bibr19-1352458512451944">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Folstein</surname><given-names>MF</given-names></name>
<name><surname>Folstein</surname><given-names>SE</given-names></name>
<name><surname>McHugh</surname><given-names>PR</given-names></name>
</person-group>. <article-title>Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician</article-title>. <source>J Psychiat Res</source> <year>1975</year>; <volume>12</volume>: <fpage>189</fpage>–<lpage>198</lpage>.</citation>
</ref>
<ref id="bibr20-1352458512451944">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fischer</surname><given-names>JS</given-names></name>
<name><surname>Rudick</surname><given-names>RA</given-names></name>
<name><surname>Cutter</surname><given-names>GR</given-names></name>
<etal/>
</person-group>. <article-title>The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment</article-title>. <source>Mult Scler</source> <year>1999</year>; <volume>5</volume>: <fpage>244</fpage>–<lpage>250</lpage>.</citation>
</ref>
<ref id="bibr21-1352458512451944">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sheridana</surname><given-names>LK</given-names></name>
<name><surname>Fitzgeralda</surname><given-names>HE</given-names></name>
<name><surname>Adams</surname><given-names>KM</given-names></name>
<etal/>
</person-group>. <article-title>Normative Symbol Digit Modalities Test performance in a community-based sample</article-title>. <source>Arch Clin Neuropsych</source> <year>2006</year>; <volume>21</volume>: <fpage>23</fpage>-<lpage>28</lpage>.</citation>
</ref>
<ref id="bibr22-1352458512451944">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stroop</surname><suffix>JR</suffix></name>
</person-group>. <article-title>Studies of interference in serial verbal reactions</article-title>. <source>J Exp Psychol</source> <year>1935</year>; <volume>18</volume>: <fpage>643</fpage>–<lpage>661</lpage>.</citation>
</ref>
<ref id="bibr23-1352458512451944">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tombaugh</surname><given-names>NT</given-names></name>
</person-group>. <article-title>Trail Making Test A and B: Normative data stratified by age and education</article-title>. <source>Arch Clin Neuropsych</source> <year>2004</year>; <volume>19</volume>: <fpage>203</fpage>–<lpage>214</lpage>.</citation>
</ref>
<ref id="bibr24-1352458512451944">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zigmond</surname><given-names>AS</given-names></name>
<name><surname>Snaith</surname><given-names>RP</given-names></name>
</person-group>. <article-title>The hospital anxiety and depression scale</article-title>. <source>Acta Psychiat Scand</source> <year>1983</year>; <volume>67</volume>: <fpage>361</fpage>-<lpage>370</lpage>.</citation>
</ref>
<ref id="bibr25-1352458512451944">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fischer</surname><given-names>JS</given-names></name>
<name><surname>LaRocca</surname><given-names>NG</given-names></name>
<name><surname>Miller</surname><given-names>DM</given-names></name>
<etal/>
</person-group>. <article-title>Recent developments in the assessment of quality of life in Multiple Sclerosis</article-title>. <source>Mult Scler</source> <year>1999</year>; <volume>5</volume>: <fpage>251</fpage>–<lpage>259</lpage>.</citation>
</ref>
<ref id="bibr26-1352458512451944">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fastenau</surname><given-names>PS</given-names></name>
<name><surname>Denburg</surname><given-names>NL</given-names></name>
<name><surname>Hufford</surname><given-names>B J</given-names></name>
</person-group>. <article-title>Adult norms for the Rey-Osterrieth Complex Figure Test and for supplemental recognition and matching trials from the Extended Complex Figure Test</article-title>. <source>Clin Neuropsychol</source> <year>1999</year>;<volume>13</volume>: <fpage>30</fpage>–<lpage>47</lpage>.</citation>
</ref>
<ref id="bibr27-1352458512451944">
<label>27.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Ball</surname><given-names>KB</given-names></name>
<name><surname>Roenker</surname><given-names>DL</given-names></name>
<name><surname>Bruni</surname><suffix>JR</suffix></name>
</person-group>. <article-title>Developmental changes in attention and visual search throughout adulthood</article-title>. In: <person-group person-group-type="editor">
<name><surname>Enns</surname><given-names>J</given-names></name>
</person-group> (ed) <source>Advances in psychology</source>. <publisher-loc>Amsterdam, the Netherlands: North-Holland</publisher-loc>: <publisher-name>Elsevier Science Publishers</publisher-name>, <year>1990</year>, pp. <fpage>489</fpage>–<lpage>508</lpage>.</citation>
</ref>
<ref id="bibr28-1352458512451944">
<label>28.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Jackson</surname><given-names>S</given-names></name>
</person-group>. <source>Research methods and statistics: a critical thinking approach</source>. <edition>3rd ed</edition>. <publisher-loc>Wadsworth</publisher-loc>: <publisher-name>Cengage Learning</publisher-name>, <year>2009</year>, p.<fpage>142</fpage>.</citation>
</ref>
<ref id="bibr29-1352458512451944">
<label>29.</label>
<citation citation-type="book">
<comment>SAS version 9.2</comment>. <publisher-name>SAS Institute Inc., SAS Campus Drive, Cary</publisher-name>, <publisher-loc>North Carolina</publisher-loc>, <year>2008</year>.</citation>
</ref>
<ref id="bibr30-1352458512451944">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Devos</surname><given-names>H</given-names></name>
<name><surname>Akinwuntan</surname><given-names>AE</given-names></name>
<name><surname>Nieuwboer</surname><given-names>A</given-names></name>
<etal/>
</person-group>. <article-title>Screening for fitness to drive after stroke: a systematic review and meta-analysis</article-title>. <source>Neurology</source> <year>2011</year>; <volume>76</volume>: <fpage>747</fpage>–<lpage>756</lpage>.</citation>
</ref>
<ref id="bibr31-1352458512451944">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Devos</surname><given-names>H</given-names></name>
<name><surname>Vandenberghe</surname><given-names>W</given-names></name>
<name><surname>Nieuwboer</surname><given-names>A</given-names></name>
<etal/>
</person-group>. <article-title>Predictors of fitness to drive in people with Parkinson disease</article-title>. <source>Neurology</source> <year>2007</year>; <volume>69</volume>: <fpage>1434</fpage>–<lpage>1441</lpage>.</citation>
</ref>
<ref id="bibr32-1352458512451944">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lincoln</surname><given-names>NB</given-names></name>
<name><surname>Radford</surname><given-names>KA</given-names></name>
<name><surname>Lee</surname><given-names>E</given-names></name>
<etal/>
</person-group>. <article-title>The assessment of fitness to drive in people with dementia</article-title>. <source>Int J Geriatr Psychol</source> <year>2006</year>; <volume>21</volume>: <fpage>1044</fpage>–<lpage>1051</lpage>.</citation>
</ref>
<ref id="bibr33-1352458512451944">
<label>33.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Lezak</surname><given-names>MD</given-names></name>
<name><surname>Howieson</surname><given-names>DB</given-names></name>
<name><surname>Loring</surname><given-names>DW</given-names></name>
</person-group>. <source>Neuropsychological assessment</source> (<edition>4th ed</edition>.). <publisher-loc>New York</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>, <year>2004</year>.</citation>
</ref>
<ref id="bibr34-1352458512451944">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Anstey</surname><given-names>KJ</given-names></name>
<name><surname>Windsor</surname><given-names>TD</given-names></name>
<name><surname>Luszcz</surname><given-names>MA</given-names></name>
<etal/>
</person-group>. <article-title>Predicting driving cessation over 5 years in older adults: Psychological well-being and cognitive competence are stronger predictors than physical health</article-title>. <source>J Am Geriatr Soc</source> <year>2006</year>; <volume>54</volume>: <fpage>121</fpage>–<lpage>126</lpage>.</citation>
</ref>
<ref id="bibr35-1352458512451944">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Uc</surname><given-names>EY</given-names></name>
<name><surname>Rizzo</surname><given-names>M</given-names></name>
<name><surname>Anderson</surname><given-names>SW</given-names></name><etal/>
</person-group>. <article-title>Impaired visual search in drivers with Parkinson’s disease</article-title>. <source>Ann Neurol</source> <year>2006</year>; <volume>60</volume>: <fpage>407</fpage>–<lpage>413</lpage>.</citation>
</ref>
<ref id="bibr36-1352458512451944">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Taylor</surname><given-names>JF</given-names></name>
</person-group>. <article-title>Vision and driving</article-title>. <source>Ophthal Physl Opt</source> <year>1987</year>; <volume>7</volume>: <fpage>187</fpage>–<lpage>189</lpage>.</citation>
</ref>
<ref id="bibr37-1352458512451944">
<label>37.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nouri</surname><given-names>FM</given-names></name>
<name><surname>Lincoln</surname><given-names>NB</given-names></name>
</person-group>. <article-title>Predicting driving performance after stroke</article-title>. <source>BMJ</source> <year>1993</year>; <volume>307</volume>: <fpage>482</fpage>–<lpage>483</lpage>.</citation>
</ref>
<ref id="bibr38-1352458512451944">
<label>38.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Radford</surname><given-names>KA</given-names></name>
<name><surname>Lincoln</surname><given-names>NB</given-names></name>
<name><surname>Lennox</surname><given-names>G</given-names></name>
</person-group>. <article-title>The effects of cognitive abilities on driving in people with Parkinson’s disease</article-title>. <source>Disabil Rehabil</source> <year>2004</year>; <volume>26</volume>: <fpage>65</fpage>–<lpage>70</lpage>.</citation>
</ref>
<ref id="bibr39-1352458512451944">
<label>39.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Radford</surname><given-names>KA</given-names></name>
<name><surname>Lincoln</surname><given-names>NB</given-names></name>
<name><surname>Murray-Leslie</surname><given-names>C</given-names></name>
</person-group>. <article-title>Validation of the Stroke Driver Screening Assessment for people with traumatic brain injury</article-title>. <source>Brain Injury</source> <year>2004</year>; <volume>18</volume>: <fpage>775</fpage>–<lpage>786</lpage>.</citation>
</ref>
<ref id="bibr40-1352458512451944">
<label>40.</label>
<citation citation-type="gov">
<collab>2009 National statistics on patient and hospital characteristics for all diagnosis of Multiple Sclerosis</collab>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="http://hcupnet.ahrq.gov/HCUPnet.jsp">http://hcupnet.ahrq.gov/HCUPnet.jsp</ext-link></comment> (<access-date>last accessed 01/16/2012</access-date>).</citation>
</ref>
</ref-list>
</back>
</article>